Ozempic Was Used by Two Million Medicare Part D Enrollees in 2024, Up from Fewer Than 150,000 in 2019 Semaglutide, the GLP-1 drug branded as Ozempic, Rybelsus, and Wegovy, was the most used GLP-1 in 2024
In a phase III clinical trial for a non-type 2 diabetic obese population (OASIS-1), researchers evaluated the safety and effectiveness of daily oral semaglutide 50mg combined with placebo and moderate-intensity lifestyle interventions
However, recent studies have revealed the potential for these compounds to also impact the pathological process of AD
A new natural sugar is in town: allulose, which is nature's GLP-1." Inspired by his talk, I wanted to explore GLP-1what it is, how it works, and how we can support its natural production through nutrition
Safety Most of Maximus products boast a significant amount of human clinical research evaluating both efficacy and safety, with safety profiles typically consisting of only mild side effects for most users